CA Patent
CA3073871A1 — Polymorphs of syk inhibitors
Assigned to Kronos Bio Inc · Expires 2019-02-28 · 7y expired
What this patent protects
Polymorphs of a bis-mesylate salt of a compound of Formula (I), are provided.
USPTO Abstract
Polymorphs of a bis-mesylate salt of a compound of Formula (I), are provided.
Drugs covered by this patent
- Venclexta (venetoclax) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.